American College Of Medical Toxicology Incorporated

American College Of Medical Toxicology Incorporated (ACMT) is a non-profit organization specializing in medical toxicology that provides expertise and services to federal agencies through contracts and grants. As the leading professional organization for medical toxicologists, ACMT leverages its knowledge and research resources to support various government initiatives related to poison control, toxicology data, and opioid overdose response. The organization maintains a Toxicology Investigators Consortium registry database, which serves as a valuable resource for federal agencies in monitoring and responding to public health issues involving exposure to toxic substances.

ACMT has been awarded numerous federal contracts by agencies within the Department of Health and Human Services, including the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and Substance Abuse and Mental Health Services Administration (SAMHSA). These contracts typically involve providing access to ACMT's toxic registry database, conducting surveillance of drug overdoses, and offering specialized training courses. For example, ACMT received a $1,842,760 contract from the FDA to characterize naloxone's clinical use, risks, benefits, and effectiveness in reversing opioid overdoses in pre-hospital settings. The organization also secured a $2,301,000 contract from the CDC for access to its Toxicology Investigators Consortium registry database, allowing staff to query the registry and conduct analyses on nonfatal drug overdoses. Additionally, ACMT has provided training courses such as the "ACMT Agents of Opportunity Training" for the CDC. These contracts are typically awarded without set-aside designations, reflecting ACMT's unique expertise in the field of medical toxicology.

While specific details about federal grant awards to ACMT are not provided in the given information, it is mentioned that the organization has received federal grants from various Department of Health and Human Services agencies. These grants likely support ACMT's work in areas such as substance use disorder, opioid overdose prevention and response, and pharmacovigilance. The organization's expertise in medical toxicology and its maintenance of comprehensive toxicology databases make it a valuable partner for federal agencies seeking to address public health challenges related to drug use, overdoses, and toxic exposures.

ACMT holds at least one Indefinite Delivery Vehicle (IDV) contract with the federal government, specifically with the Food and Drug Administration. Under this IDV (contract number 75F40122D00028), ACMT has received multiple delivery orders for various services. One such order, valued at $565,000, was for the "NEAR REAL-TIME SURVEILLANCE OF STIMULANTS IN THE OVERDOSE CRISIS - DRUG OVERDOSE TOXICO-SURVEILLANCE (DOTS) EXPANSION." Another delivery order under this IDV, worth $6,533,650, was for online access to ACMT's toxic registry and support for COVID-19 related sub-registries. These delivery orders demonstrate the flexibility of the IDV in allowing the FDA to access ACMT's specialized toxicology services and data resources as needed, supporting the agency's efforts in monitoring adverse events, medical product safety, and public health surveillance related to drug use and overdoses.